Divi's Laboratories Limited

NSE DIVISLAB.NS

Divi's Laboratories Limited Free Cash Flow for the year ending March 31, 2024: USD 30.93 M

Divi's Laboratories Limited Free Cash Flow is USD 30.93 M for the year ending March 31, 2024, a -87.20% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Divi's Laboratories Limited Free Cash Flow for the year ending March 31, 2023 was USD 241.72 M, a 53.13% change year over year.
Divi's Laboratories Limited Free Cash Flow for the year ending March 31, 2022 was USD 157.86 M, a 11.49% change year over year.
Divi's Laboratories Limited Free Cash Flow for the year ending March 31, 2021 was USD 141.59 M, a 3,159.93% change year over year.
Divi's Laboratories Limited Free Cash Flow for the year ending March 31, 2020 was USD 4.34 M, a -86.36% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NSE: DIVISLAB.NS

Divi's Laboratories Limited

CEO	Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
IPO Date	March 12, 2003
Location	India
Headquarters	Divi Towers
Employees	9,741
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Key trends

Past 5 years